Both in Pharmaceuticals
ZOETIS vs Alnylam Pharmaceuticals
Over the past year ZTS returned −28.3% and ALNY returned −62.0%; their daily moves had a correlation of 0.12.
ZTS −28.3% ALNY −62.0%Growth of $1, one year, split-adjusted
| Metric | ZTS | ALNY |
|---|---|---|
| Price | $89.20 | $161.08 |
| Market cap | $36.86B | $21.57B |
| Today | +7.48% | +0.74% |
| 1 month | +25.1% | −28.1% |
| 6 months | −19.8% | −46.8% |
| Year to date | −29.1% | −59.5% |
| 1 year | −38.2% | −62.9% |
| Revenue growth (YoY) | −0.2% | +16.7% |
| Gross margin | 72.7% | 75.2% |
| Net margin | 28.0% | 148.6% |
| P/E (TTM) | 14.1× | 7.9× |
| Price / sales | 3.9× | 4.3× |
| Net cash | -$7.37B | $2.57B |
| Dividend yield | 2.38% | — |
| Volatility (60d) | 32.1% | 72.8% |
| Short % of float | 4.2% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).